Form 4: Astera Labs CFO Michael Tate Reports Share Transfers and Sales

Chief Financial Officer Michael Tate of Astera Labs reports gifting shares to trusts and a non-affiliated entity, as well as selling shares on February 26, 2025.

Summary

• Michael Tate, the CFO of Astera Labs, filed a Form 4 detailing changes in his beneficial ownership of the company's stock.
• On February 26, 2025, Tate gifted 125,800 shares to the GlobalStar 2025 CRUT (CRUT Trust) and sold 125,800 shares at a weighted average price of $82.5349.
• Additionally, on February 27, 2025, Tate gifted 125,800 shares to a non-affiliated entity.
• These transactions resulted in adjustments to the number of shares held directly and indirectly through the Tate Trust and the CRUT Trust.
• After these transactions, Tate directly owns 244,242 shares and indirectly owns 1,118,996 shares through the Tate Trust.
• The filing clarifies that Tate disclaims beneficial ownership of shares held by the trusts, except to the extent of his pecuniary interest.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing share transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

Form 4 filings are standard practice for company insiders to report transactions in their company's stock, providing transparency to investors.

Stakeholder Impact

• Shareholders are informed about the CFO's transactions in the company's stock.
• The market may react to the sale of shares by a key executive, although the gifts are unlikely to have a significant impact.

Key Dates